ELRIN: a European diagnostic long read sequencing network | ESHG 2025

In this talk recorded at ESHG 2025, Prof. Olaf Reiss introduces the European Long Read Innovation Network (ELRIN) consortium, an initiative dedicated to driving the adoption of cutting-edge genomic testing. Their goal is to ensure that advanced tools are readily accessible and practical for potential clinical use across diverse settings.

Biography

Prof. Riess, MD, is full professor for Medical Genetics and Director of the Institute of Medical Genetics and Applied Genomics. He is also founder and acting director of the Rare Disease Center Tübingen. He has more than 20 years of experience in clinical genetics and research of genetically caused disorders. He currently is and has been coordinator of numerous international, European and national consortia such as EUROSCA, MEFOPA, TECHGENE, RATstream, Neuromics, and SOLVE-RD (together with Holm Graessner). He is also PI and spokesperson of one of four NGS Competence Centres in Germany.

Please note:

This is independent, investigator-led research using Oxford Nanopore technology. Oxford Nanopore products are for research use only, and not for use in diagnostic procedures.